In-Depth Analysis of the Travel Vaccines Market: Growth Opportunities, Key Trends, and Forecast 2025-2034

What industry-specific factors are fueling the growth of the travel vaccines market?
The surge in travel and tourism is predicted to fuel the expansion of the travel vaccine market in the future. Travel and tourism involve the transport of individuals or objects, including vehicles like trains, ships, planes, and other modes of transport, across different distant geographical locations. Travel vaccines benefit tourists and travelers by safeguarding their health while on foreign trips. For example, the United Nations World Tourism Organization (UNWTO), an intergovernmental organization promoting tourism based in Spain, reported in January 2023 that over 900 million tourists traveled abroad in 2022. This figure is twice that of 2021 and yet 63% higher than the levels before the pandemic. Consequently, the growth in travel and tourism is leading to the expansion of the travel vaccine market.

Get Your Travel Vaccines Market Report Here:
https://www.thebusinessresearchcompany.com/report/travel-vaccines-global-market-report

What Is the projected market size and growth rate for the travel vaccines market?
Over the past few years, the travel vaccines market has experienced significant growth. Its market size is projected to increase from $4.73 billion in 2024 to $5.14 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.6%. This growth during the historical period can be credited to factors such as heightened international travel, government actions for travel health, global spread of diseases, increasing awareness among travellers, and the burgeoning travel and tourism sector.

In the upcoming years, a substantial escalation is projected in the travel vaccines market, with an estimated worth of $7.49 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.9%. Factors responsible for this growth during the forecast period include the escalating cases of business travels, heightened risks of emerging infectious diseases, government regulations and entry prerequisites, the burgeoning interest in exotic travel destinations, and partnerships between governments and pharmaceutical firms. Key trends for the forecast period encompass customised vaccination tactics, market extension to non-endemic areas, embracing digital health solutions, regulatory backing, expedited approvals and pioneering advancements.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What new trends are reshaping the travel vaccines market and its opportunities?
The trend of product innovation is increasingly becoming significant in the travel vaccine market. Major businesses in the travel vaccine market are creating novel vaccines to maintain their market standing. For example, Takeda Pharmaceutical Company Limited, a pharmaceutical organization from Japan, received approval for QDENGA (Dengue Tetravalent Vaccine) (TAK-003), intended for preventing dengue disease caused by any serotype among individuals aged six to 45, from the Indonesia National Agency for Drug and Food Control in August 2022. Regardless of an individual's previous exposure to the illness, QDENGA demonstrated three years post vaccination that it continued to offer comprehensive protection against dengue illness and hospitalization.

What major market segments define the scope and growth of the travel vaccines market?
The travel vaccines market covered in this report is segmented -

1) By Disease: Hepatitis A, Diphtheria, Pertussis, And Tetanus (DPT), Yellow Fever, Typhoid, Hepatitis B, Measles And Mumps, Rabies, Meningococcal, Other Diseases,
2) By Composition: Mono Vaccines, Combination Vaccines
3) By Booking Channel: Online Booking, In-Person Booking
4) By Application: Domestic Travel, Outbound Travel

Subsegments:
1) By Hepatitis A: Inactivated Hepatitis A Vaccine, Combination Vaccines
2) By Diphtheria, Pertussis, And Tetanus (DPT): DTP Vaccine (Diphtheria, Tetanus, Pertussis), DTaP Vaccine (Diphtheria, Tetanus, And Acellular Pertussis)
3) By Yellow Fever: Live Attenuated Yellow Fever Vaccine, Booster Dosage Vaccines
4) By Typhoid: Inactivated Typhoid Vaccine, Live Attenuated Typhoid Vaccine
5) By Hepatitis B: Recombinant Hepatitis B Vaccine, Combination Vaccines
6) By Measles And Mumps: Measles, Mumps, And Rubella (MMR) Vaccine, Measles And Rubella (MR) Vaccine
7) By Rabies: Rabies Pre-exposure Prophylaxis (PrEP), Rabies Post-exposure Prophylaxis (PEP)
8) By Meningococcal: Meningococcal Conjugate Vaccine, Meningococcal B Vaccine
9) By Other Diseases: Japanese Encephalitis, Cholera, Influenza, Other Emerging Travel Vaccines

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=11918

Which region dominates the travel vaccines market?
North America was the largest region in the travel vaccines market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the travel vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Which key market leaders are driving the travel vaccines industry growth?
Major companies operating in the travel vaccines market include Pfizer Inc., Johnson and Johnson, Merck & Co. Inc., Sanofi SA, GlaxoSmithKline plc, Biological E. Limited, Takeda Pharmaceutical Company Limited, Novavax Inc., Emergent BioSolutions UK, Serum Institute of India Pvt. Ltd., Dynavax Technologies, Bavarian Nordic A/S, Valneva SE, Panacea Biotec, Vabiotech, Inovio Pharmaceuticals, Bharat Biotech International Limited, Altimmune Inc., Bio Farma, Vaxart Inc.

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=11918&type=smp

What Is Covered In The Travel Vaccines Global Market Report?

• Market Size Forecast: Examine the travel vaccines market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the travel vaccines market for a structured understanding.
• Key Players Overview: Analyze major players in the travel vaccines market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the travel vaccines market.
• Segment Contributions: Evaluate how different segments drive overall growth in the travel vaccines market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the travel vaccines market.
• Industry Challenges: Identify potential risks and obstacles affecting the travel vaccines market.
• Competitive Landscape: Review strategic developments in the travel vaccines market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.